Zevra Therapeutics (ZVRA) Goodwill & Intangibles (2023 - 2026)

Zevra Therapeutics has reported Goodwill & Intangibles for 4 years, with the latest figure at $10.8 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 83.3% year-over-year to $10.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.8 million (down 83.3% YoY), and the FY2025 full-year result was $11.1 million, down 84.91% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $10.8 million, down from $11.1 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $75.3 million in Q3 2024, with the low at $6.7 million in Q1 2024.
• Historically, Goodwill & Intangibles has averaged $27.9 million across 4 years, with a median of $11.3 million in 2025.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles jumped 999.75% — and 2025, when it slumped 84.91%.
• Zevra Therapeutics' Goodwill & Intangibles stood at $6.7 million in 2023, then jumped by 999.75% to $73.7 million in 2024, then tumbled by 84.91% to $11.1 million in 2025, then decreased by 2.84% to $10.8 million in 2026.
• The last three Goodwill & Intangibles figures came in at $10.8 million (Q1 2026), $11.1 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.